Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:95:50-60.
doi: 10.1016/j.ejim.2021.10.031. Epub 2021 Nov 25.

Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave

Affiliations

Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave

Anna Staudt et al. Eur J Intern Med. 2022 Jan.

Abstract

Background: For a better understanding of the factors underlying the Post-Acute COVID Syndrome, we studied the relationship between symptoms and functional alterations in COVID-19 patients 10 months after hospitalization.

Methods: One-hundred-one patients hospitalized between March 1st and June 30th 2020 participated in a follow-up visit for an assessment of clinical history, comorbidities, lung function, physical capacity and symptoms, including the SGRQ for health-related quality of life, PHQ-9-D for depression, and SOMS-2 J for somatoform disorders. Data were analyzed by univariate comparisons and multiple logistic regression analyses.

Results: Median age was 60 years, 42% were female, 76% had at least one comorbidity, the median length of the hospital stay was 8 days, 19% had been on the ICU. The most prevalent symptoms included shortness of breath (49%), fatigue (49%) and cognitive impairment (39%). Signs of major depression (PHQ-9-D ≥ 10) occurred in 28%/2% (p < 0.05) of patients with/without self-reported cognitive impairment, with median total SGRQ score being 25.4/5.3 (p < 0.05). There were associations between shortness of breath and BMI, SGRQ and hemoglobin levels; between fatigue, SGRQ and PHQ-9-D; and between cognitive impairment and PHQ-9-D (p < 0.05 each) but not with lung function or physical capacity. Characteristics of the acute disease were not related to symptoms.

Conclusions: The findings demonstrate that 10 months after discharge from a hospital stay due to COVID-19, the percentages of patients with symptoms were high. Symptoms showed a consistent pattern but could not be attributed to altered lung function or physical capacity. Our results suggest a role for alternative etiologies including psychosocial factors.

Keywords: Depression; HrQoL; Lung function; Post-Acute COVID Syndrome; Somatization; Symptoms.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Frequency of symptoms (absolute numbers) in the 101 participants of the follow-up visit. Due to the fact that the total number was n = 101, the numerical values of percentages are virtually the same. Data are given separately for males (blue) and females (red).
Fig. 2
Fig. 2
Percentages of patients in the follow-up visit (n = 101) showing specific counts of symptoms (red) or abnormal values according to LLN or ULN for lung function and physical performance (blue). SpO2 = oxygen saturation from pulse oximetry, FEV1 = forced expiratory volume in 1 s, TLC = total lung capacity, 6-MWD = 6 min walk distance, LLN = lower limit of normal. For functional measures, percentages were in the range of 5% that is expected by definition in a normal population, except for FEV1, possibly because of the fact that about 10% of patients had a history of obstructive airway disease.
Fig. 3A
Fig. 3A
Box plots of functional measures in percent predicted, or percentages for SpO2 and FEV1/FVC, for the two groups of patients either reporting or not reporting shortness of breath at the follow-up visit. SpO2 = oxygen saturation from pulse oximetry, FEV1 = forced expiratory volume in 1 s, FVC = forced vital capacity, TLC = total lung capacity, RV = residual capacity, 6-MWD = 6 min walk distance. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. In none of the measures there were statistically significant differences between the two groups (Mann-Whitney U-test).
Fig. 3B
Fig. 3B
Box plots of functional measures in percent predicted, or percentages for SpO2 and FEV1/FVC, for the two groups of patients either reporting or not reporting fatigue at the follow-up visit. SpO2 = oxygen saturation from pulse oximetry, FEV1 = forced expiratory volume in 1 s, FVC = forced vital capacity, TLC = total lung capacity, RV = residual capacity, 6-MWD = 6 min walk distance. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. In none of the measures there were statistically significant differences between the two groups (Mann-Whitney U-test).
Fig. 3C
Fig. 3C
Box plots of functional measures in percent predicted, or percentages for SpO2 and FEV1/FVC C, for the two groups of patients either reporting or not reporting cognitive impairment at the follow-up visit. SpO2 = oxygen saturation from pulse oximetry, FEV1 = forced expiratory volume in 1 s, FVC = forced vital capacity, TLC = total lung capacity, RV = residual capacity, 6-MWD = 6 min walk distance. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. In none of the measures there were statistically significant differences between the two groups (Mann-Whitney U-test).
Fig. 4A
Fig. 4A
Box plots of the scores of the PHQ-9-D and SGRQ (total and three sub-scores) for the two groups of patients either reporting or not reporting shortness of breath at the follow-up visit. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. There were statistically significant differences between the two groups (p < 0.05 each, Mann-Whitney U-test) for all of the scores.
Fig. 4B
Fig. 4B
Box plots of the scores of the PHQ-9-D and SGRQ (total and three sub-scores) for the two groups of patients either reporting or not reporting fatigue at the follow-up visit. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. There were statistically significant differences between the two groups (p < 0.05 each, Mann-Whitney U-test) for all of the scores.
Fig. 4C
Fig. 4C
Box plots of the scores of the PHQ-9-D and SGRQ (total and three sub-scores) for the two groups of patients either reporting or not reporting cognitive impairment at the follow-up visit. The boxes indicate the quartiles, the horizontal bar the median value, the whiskers the 10- and 90-percentiles, and the circles points outside of these. There were statistically significant differences between the two groups (p < 0.05 each, Mann-Whitney U-test) for all of the scores.

Similar articles

Cited by

References

    1. Robert Koch Institut (2021), COVID-19: Fallzahlen in deutschland und weltweit, in: rki.de, 11/08/2021, https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Fallzahlen...., accessed: 11/08/2021.
    1. European Centre for disease prevention and control (2021), COVID-19 situation update for the EU/EEA, as of 10 August 2021, in: ecdc.europa.eu, 10/08/2021, https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea, accessed: 08/08/2021.
    1. Richardson S., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020;323(20):2052–2059. doi: 10.1001/jama.2020.6775. - DOI - PMC - PubMed
    1. Huang C., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Guan W.J., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed